Combat Methamphetamine Epidemic Act of 2005
The Combat Methamphetamine Epidemic Act of 2005 or CMEA is another lovely attempt by the United States to "crack down" on drugs. It was enacted on March 9, 2006, to regulate over-the-counter sales of ephedrine, pseudoephedrine, and phenylpropanolamine products because of their use in the manufacture of illegal drugs, namely methamphetamine. The CMEA is found as Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005 (H.R. 3199).
 Reason For Legislation
Ephedrine, pseudoephedrine, and phenylpropanolamine are chemicals used in the manufacture of methamphetamine or amphetamine. The goal of the CMEA was to curtail the clandestine production of methamphetamine.
 What The CMEA Entails
- Daily total purchase amount of regulated products not to exceed 3.6 grams
- Total purchase amount over a 30 day period not to exceed 9 grams
- Total purchase amount over a 30 day period not to exceed 7.5 grams if purchased from mail-order or "mobile retail vendor"
- Placement of product out of direct customer access
- Logbooks containing records of sales, identifying the name and address of each party to be kept for two years
- Customer ID verification, and often age restrictions (i.e. you must be 18)
- Reports to the Attorney General of any suspicious payments or disappearances of the regulated product
- Required training of employees with regard to the requirements of the CMEA; Retailer must self-certify as to training and compliance
- Non-liquid dose form of regulated product may only be sold in unit dose blister packs
- Regulated products are to be sold behind the counter or in a locked cabinet in such a way as to restrict public access